Chris Middendorf

Chris Middendorf

Hogan Lovells

Contact
View Bio
RSS

Latest Posts › Regulatory Reform

Share:

Reshoring EO aims to streamline permitting, approval, and oversight of US drug manufacturing

On May 5, 2025, President Donald Trump signed an Executive Order (EO) aiming to promote American-made prescription drugs (“Reshoring Manufacturing EO”). The EO directs federal agencies to eliminate regulatory hurdles,...more

5/8/2025  /  Executive Orders , Food and Drug Administration (FDA) , Government Agencies , Investment , National Security , Pharmaceutical Industry , Prescription Drugs , Regulatory Reform , Regulatory Requirements , Supply Chain
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide